| abstract |
The present invention provides a compound which has an inhibitory activity in specific lysine demethylase 1 and is useful as a medicinal agent such as a prophylactic or therapeutic agent for cancer and diseases of the central nervous system. The present invention relates to a compound represented by the formula (I) [wherein A represents a hydrocarbon group or a heterocyclic ring which may have a substituent; R represents H or a hydrocarbon group or heterocyclic ring which may have a substituent; A and R can be joined together to form a ring that can have a substituent; Q1, Q2, Q3 and Q4 independently represent a hydrogen atom or a substituent; Q1 and Q2 or Q3 and Q4 can be joined together to form a ring which can have a substituent; X represents H or a saturated linear or cyclic hydrocarbon group which may have a substituent; Y1, Y2 and Y3 independently represent H or a hydrocarbon or heterocyclic ring group which may have a substituent; X and Y1 or Y1 and Y2 can be joined together to form a ring that can have a substituent; and Z1, Z2 and Z3 independently represent H or a substituent] or a salt thereof. |